HRP20180079T1 - Transdermalni sustav za isporuku - Google Patents

Transdermalni sustav za isporuku Download PDF

Info

Publication number
HRP20180079T1
HRP20180079T1 HRP20180079TT HRP20180079T HRP20180079T1 HR P20180079 T1 HRP20180079 T1 HR P20180079T1 HR P20180079T T HRP20180079T T HR P20180079TT HR P20180079 T HRP20180079 T HR P20180079T HR P20180079 T1 HRP20180079 T1 HR P20180079T1
Authority
HR
Croatia
Prior art keywords
nitrite
hydrogel
active agent
layer
pain
Prior art date
Application number
HRP20180079TT
Other languages
English (en)
Croatian (hr)
Inventor
Christopher Barry Wood
Hugh Semple Munro
Nicholas David Boote
Joanne Ellen Stewart
Arthur Tudor Tucker
Original Assignee
Edixomed Limited
First Water Limited
Queen Mary University Of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edixomed Limited, First Water Limited, Queen Mary University Of London filed Critical Edixomed Limited
Publication of HRP20180079T1 publication Critical patent/HRP20180079T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
HRP20180079TT 2013-05-20 2014-05-20 Transdermalni sustav za isporuku HRP20180079T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201309092A GB201309092D0 (en) 2013-05-20 2013-05-20 Transdermal delivery system
EP14727614.1A EP2908873B1 (en) 2013-05-20 2014-05-20 Transdermal delivery system
PCT/GB2014/051544 WO2014188175A1 (en) 2013-05-20 2014-05-20 Transdermal delivery system

Publications (1)

Publication Number Publication Date
HRP20180079T1 true HRP20180079T1 (hr) 2018-04-06

Family

ID=48747065

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20180079TT HRP20180079T1 (hr) 2013-05-20 2014-05-20 Transdermalni sustav za isporuku

Country Status (18)

Country Link
US (1) US10010648B2 (cg-RX-API-DMAC7.html)
EP (1) EP2908873B1 (cg-RX-API-DMAC7.html)
JP (1) JP6446035B2 (cg-RX-API-DMAC7.html)
CN (1) CN105431175B (cg-RX-API-DMAC7.html)
AU (1) AU2014270116B2 (cg-RX-API-DMAC7.html)
DK (1) DK2908873T3 (cg-RX-API-DMAC7.html)
ES (1) ES2658037T3 (cg-RX-API-DMAC7.html)
GB (1) GB201309092D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20180079T1 (cg-RX-API-DMAC7.html)
HU (1) HUE035847T2 (cg-RX-API-DMAC7.html)
LT (1) LT2908873T (cg-RX-API-DMAC7.html)
NO (1) NO2908873T3 (cg-RX-API-DMAC7.html)
PL (1) PL2908873T3 (cg-RX-API-DMAC7.html)
PT (1) PT2908873T (cg-RX-API-DMAC7.html)
RS (1) RS56833B1 (cg-RX-API-DMAC7.html)
SI (1) SI2908873T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201800030T1 (cg-RX-API-DMAC7.html)
WO (1) WO2014188175A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201420761D0 (en) 2014-11-21 2015-01-07 Edixomed Ltd And First Water Ltd Dressing system
GB201520990D0 (en) * 2015-11-27 2016-01-13 Edixomed Ltd Dressing system
TWI605843B (zh) * 2016-12-21 2017-11-21 嘉藥學校財團法人嘉南藥理大學 氣相經皮吸收系統
WO2019166572A1 (en) 2018-02-28 2019-09-06 Pharming Intellectual Property B.V. Pharmaceutical system for transdermal administration of a c1 -esterase inhibitor
US12220493B2 (en) 2018-07-16 2025-02-11 Systagenix Wound Management, Limited Nitric oxide producing collagen/ORC dressing
AU2020211392A1 (en) * 2019-01-11 2021-07-22 Noxsano Inc. Electrochemical gasotransmitter generating compositions and bimetallic cells for the generation of gasotransmitters
JP7686578B2 (ja) * 2019-06-04 2025-06-02 サーティー レスピラトリー リミテッド 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
BR112021023832A8 (pt) 2019-06-04 2023-02-28 Thirty Holdings Ltd Métodos e composições para geração de óxido nítrico e usos dos mesmos
GB2609799B (en) * 2020-04-02 2025-05-28 Smith & Nephew Wound dressing
GB202004868D0 (en) * 2020-04-02 2020-05-20 Smith & Nephew Wound care compositions and methods of preparation thereof
AU2021259360A1 (en) 2020-04-23 2022-12-01 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating SARS-CoV and SARS-CoV-2
CN115768413B (zh) 2020-04-23 2025-10-24 三十呼吸有限公司 用于治疗及抗击结核病的方法和组合物
CN113101053A (zh) * 2021-03-30 2021-07-13 上海健康医学院 一种可释放一氧化氮的创伤敷料

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI833438A7 (fi) 1982-10-26 1984-04-27 Kennecott Corp Tvao varmvalsar med hoeg hastighet, foerfarande och en smal remsprodukt
EP0139127A1 (en) * 1983-08-22 1985-05-02 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Transdermal drug delivery device and its preparation
JP2002521526A (ja) 1998-07-31 2002-07-16 ファースト ウォーター リミテッド 疎水性ポリマーを含む生体接着剤組成物
GB9905425D0 (en) 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
GB0021317D0 (en) * 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
CA2323382C (en) 2000-10-17 2004-04-13 Pharma Mag Inc. Wound dressing
GB0715556D0 (en) 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
GB0715554D0 (en) 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US20100055161A1 (en) 2008-08-27 2010-03-04 Dong June Ahn Hydrogel face mask for delivering skin care agents
ES2633618T3 (es) * 2009-10-14 2017-09-22 Theravasc Inc. Formulaciones farmacéuticas de nitrito y sus usos
WO2011076216A2 (en) 2009-12-22 2011-06-30 Rigshospitalet, Copenhagen University Hospital Wound care products
GB201309091D0 (en) * 2013-05-20 2013-07-03 Edixomed Ltd Dressing system

Also Published As

Publication number Publication date
JP2016518458A (ja) 2016-06-23
ES2658037T3 (es) 2018-03-08
EP2908873B1 (en) 2017-10-18
EP2908873A1 (en) 2015-08-26
AU2014270116A1 (en) 2015-12-10
US20160089473A1 (en) 2016-03-31
NO2908873T3 (cg-RX-API-DMAC7.html) 2018-03-17
RS56833B1 (sr) 2018-04-30
LT2908873T (lt) 2018-02-12
WO2014188175A1 (en) 2014-11-27
PL2908873T3 (pl) 2018-06-29
HUE035847T2 (en) 2018-05-28
AU2014270116B2 (en) 2017-12-21
SI2908873T1 (en) 2018-04-30
DK2908873T3 (en) 2018-01-22
SMT201800030T1 (it) 2018-03-08
US10010648B2 (en) 2018-07-03
PT2908873T (pt) 2018-01-23
GB201309092D0 (en) 2013-07-03
CN105431175B (zh) 2018-12-28
JP6446035B2 (ja) 2018-12-26
CN105431175A (zh) 2016-03-23

Similar Documents

Publication Publication Date Title
HRP20180079T1 (hr) Transdermalni sustav za isporuku
HRP20180275T1 (hr) Sustav zavoja
JP2016518458A5 (cg-RX-API-DMAC7.html)
JP2016522829A5 (cg-RX-API-DMAC7.html)
MX2015012760A (es) Composicion farmaceutica que comprende un activador de ampk y un agente serotonergico y metodos de uso de la misma.
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
ATE486593T1 (de) Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack
NZ629468A (en) Tamper resistant immediate release formulations
EA201691193A1 (ru) Система доставки лекарственных средств
EA201300704A1 (ru) Трансдермальная терапевтическая система для введения активного вещества
PE20141070A1 (es) Composiciones estables de povidona yodada con antiinflamatorios esteroideos o no esteroideos
NZ597237A (en) Sublingual apomorphine
NZ582049A (en) Transdermal delivery devices assuring an improved release of an active principle through a biological interface
CL2014002524A1 (es) Composicion farmaceutica que comprende un compuesto activo de formula 1, antagonista de ccr3, dos diluyentes, un aglutinante, un desintegrante y un lubricante; formas de dosificacion en capsula, comprimido o comprimido recubierto con pelicula.
BR112015025805A2 (pt) compostos de ligação de nh3 e métodos para inibir o transporte de fosfato
MX349572B (es) Parche no acuoso.
MY173582A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
CO2022001663A2 (es) Composiciones medicinales y/o farmacéuticas para la instilación intravesical, preparación y uso de las mismas
MX2022012967A (es) Tratamiento de la hidradenitis supurativa.
CN103156730A (zh) 异种脱细胞真皮基质护创系统
JP6028107B2 (ja) ポビドンヨードの新たな用途
RU2012133272A (ru) Средство пептидной структуры, обладающее анальгетическим, противовоспалительным действием и лекарственные формы на его основе
CN103622782B (zh) 生物膜护创系统
Guo et al. Preparation and performance evaluation of the analgesic and anti-inflammatory effects of chitosan composite materials
Connors et al. Wide variation in naloxone dosing recommendations for acute opioid toxicity